# SLND Versus Non-Dissection Following ESD for T1a Stage Esophageal Squamous Cell Carcinoma

> **NCT06979986** · NA · NOT_YET_RECRUITING · sponsor: **Fujian Cancer Hospital** · enrollment: 102 (estimated)

## Conditions studied

- Esophageal Cancer

## Interventions

- **PROCEDURE:** Endoscopic Submucosal Dissection with Systematically mediastinal Lymph Node Dissection
- **PROCEDURE:** Endoscopic Submucosal Dissection without SLND

## Key facts

- **NCT ID:** NCT06979986
- **Lead sponsor:** Fujian Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2025-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06979986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06979986, "SLND Versus Non-Dissection Following ESD for T1a Stage Esophageal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06979986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*